Home > Press > Ben Franklin Funding Awarded to PSU nanotechnology project
Abstract:
Penn State's Nanotechnology Research and Commercialization project has been awarded $3.5 million from Pennsylvania's BFTDA.
Penn State's Nanotechnology Research and Commercialization project has been awarded $3.5 million from Pennsylvania's Ben Franklin Technology Development Authority (BFTDA) to support nanotechnology education, research and commercialization.
The grant was part of $13.6 million in BFTDA funding announced recently to support Gov. Edward G. Rendell's technology-focused economic development strategy. According to the announcement from the Community and Economic Development Secretary, the grant will provide state co-funding for federally sponsored nanotechnology research centers at Penn State.
Hank Foley, associate vice president for research at Penn State, says, "Penn State is an engine for economic growth in the central region and the Commonwealth. This grant is essential to us and will be used to fund new research in high risk - high reward areas, to improve our infrastructure and facilities, to continue workforce development and education in partnership with the State System of Higher Education and community colleges and to enhance the commercialization of nanotechnology to spur the growth of new business."
The BFTDA grant provides leverage for Penn State to procure further funding from industry and federal agencies such as the National Science Foundation. The BFTDA also provides separate funding for four Ben Franklin Technology Partners throughout Pennsylvania that identify the most promising technological ventures providing them with technical assistance and capital.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
Ben Franklin Technology Development Authority
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||